Search clinical trials for: quantification of BRAF and NRAS mutation

Total 989 results

Centre Hospitalier Universitaire de Nice

Unknown

Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT ) (MALT)

Malignant Melanoma Stage III | Malignant Melanoma Stage IV
Institut de Cancérologie de Lorraine

Completed

Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer (CircuLOR-1)

Metastatic Colorectal Cancer

France
Institut de Cancérologie de Lorraine

Completed

Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer (ColoBEAM)

Colorectal Cancer Metastatic

France
Medical University of Graz

Completed

Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.

Nevi

Austria
Assiut University

Not yet recruiting

Evaluation of Some Risk Factors Associated With Colorectal Cancer

Colorectal Neoplasms
Manisha Shah
National Comprehensive Cancer Network

Completed

Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Jinsong Wu

Completed

Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid Detection

Glioma, Malignant

China
Royal Cornwall Hospitals Trust
Biocartis

Completed

KEBI-Cyto Study - Use of the Biocartis Idylla

Pancreatic Adenocarcinoma | Lung Cancer

United Kingdom
Hospices Civils de Lyon

Unknown

MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS (RESECT)

Glioblastoma

France
MiraKind

Recruiting

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

Cancer

United States
Centre Hospitalier Universitaire de Nice

Terminated

Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders

Alzheimer's Disease

France
Tianjin Medical University Cancer Institute and...

Recruiting

Efficacy and Safety of Sintilimab Combined With Regorafenib and Cetuximab / Sintilimab Combined With Regorafenib in Posterior Line Therapy of Advanced Colorectal Cancer (Regosinti)

Sintilimab, Cetuximab, Regorafenib,Combine,mCRC

China
University Hospital, Bordeaux

Completed

Assessment of Emphysema Using 1.5T MRI With UTE Pulse Sequences (EMPHYREM)

Emphysema

France
University Hospital, Clermont-Ferrand

Unknown

Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis (STEA-MRI)

MRI | Hepatic Steatosis | Liver Biopsy | Quantification

France
Meyer Children's Hospital IRCCS

Recruiting

Subtypes and Prognostic Factors in Erdheim-Chester Disease

Erdheim-Chester Disease

Italy
University Hospital, Clermont-Ferrand

Unknown

Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI (IVIM-MRI)

MRI | Liver Fibrosis | Liver Biopsy | IVIM

France
Origin Sciences
Royal Infirmary of Edinburgh

Recruiting

Feasibility of the Oricol™ Sampling Device to Retrieve Vagina Mucus (Wall) Samples for Genomic & Epigenetic Analysis. (Ellele-01)

Diagnosis | Vagina Disease

United Kingdom
Fondation Lenval

Completed

Mid-Term Follow-up Assessment After Exposure to Natural Disaster (MFAE-ND)

Psychiatric Disorder

France
Centre Hospitalier Intercommunal de Toulon La Seyne...
Assistance Publique Hopitaux De Marseille; F-CRIN INNOVTE Research Network

Not yet recruiting

DVT Burden and the Risk of Post-thrombotic Syndrome (DVT-Burden)

Postthrombotic Syndrome

France
Ziv Hospital

Unknown

Clopidogrel Resistance in Stroke Patients From Different Ethnicities

Ischemic Stroke | Clopidogrel, Poor Metabolism of
Centre Hospitalier Intercommunal de Toulon La Seyne...
Sainte-Anne Military Teaching Hospital

Completed

Drug Wastage : Observational Study in the Operating Rooms of France (GAME-OvBLOC)

Drug Use

France, Monaco, Mayotte, Guadeloupe
Craig L Slingluff, Jr
Celldex Therapeutics

Active, not recruiting

Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) (Mel66)

Melanoma | Ocular Melanoma | Uveal Melanoma

United States
Elin Tragardh
Lund University

Recruiting

AI-based Measurements of Tumour Burden in PSMA PET-CT

Prostate Cancer

Sweden
Jinsong Wu

Completed

Molecular Pathology Research Project of Glioma

Glioma, Malignant

China
Suhu Liu

Recruiting

Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)

Acute Myeloid Leukemia

United States
Melanoma Institute Australia
Novartis

Recruiting

Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma (MatchMel)

Melanoma

Australia
The National Center of Oncology, Azerbaijan

Unknown

Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy (CERVIPIB)

Cervical Cancer

Azerbaijan
Ottawa Hospital Research Institute

Completed

Antimicrobial Pharmacokinetics in Critically Ill Adults During Sustained Low Efficiency Dialysis (SLED)

Critical Illness | Pharmacokinetics | Kidney Injury

Canada
Joint Authority for Päijät-Häme Social and Health...
Helsinki University Central Hospital

Completed

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Actinic Keratoses

Finland
University Hospital, Tours

Recruiting

Metabo-lipidomics of the Ocular Surface for Cataract Surgery (CATARACTOMIQUE)

Age-related Cataract

France
Assistance Publique - Hôpitaux de Paris
Groupe Hospitalier Pitie-Salpetriere

Terminated

ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic (ACORES-2)

History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection

France
UNC Lineberger Comprehensive Cancer Center
GlaxoSmithKline

Completed

LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations

Unresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant Melanoma

United States
Hospices Civils de Lyon

Unknown

Netrin-1 & Hepatocellular Carcinoma HCC (HCC-Net)

HCC

France
AGO Research GmbH

Completed

Prevalence of BRCA in Patients With Ovarian Cancer

Ovarian Cancer | BRCA Status

Germany
Celltrion

Completed

Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects

Healthy Subject

Korea, Republic of
Chang Gung Memorial Hospital

Recruiting

To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

Postoperative Complications | Enhanced Recovery After Surgery | Pituitary Tumor

Taiwan
Vastra Gotaland Region
Karolinska Institutet; Oslo University Hospital; Aarhus University Hospital; Sahlgrenska... and other collaborators

Not yet recruiting

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Glioblastoma, IDH-wildtype | MGMT-Methylated Glioblastoma
National Cancer Institute (NCI)

Active, not recruiting

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Soft Tissue Sarcoma | Osteosarcoma | Ewing Sarcoma | Malignant Glioma | Ependymoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Rhabdomyosarcoma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma and other conditions

United States, Puerto Rico
The Hong Kong Polytechnic University

Not yet recruiting

Effects and Mechanisms of RAS Training on Upper-limb Movements in PD Patients

Parkinson Disease | Electroencephalography | Acoustic Stimulation
Centre Henri Becquerel

Completed

Study of ESR1 Mutations in Metastatic Breast Cancer (FMER)

Metastatic Breast Cancer

France
Istituti Clinici Scientifici Maugeri SpA

Recruiting

Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis

Multiple Sclerosis

Italy
Hospices Civils de Lyon

Unknown

MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma (CHLOROTRAMMEL)

Metastatic NRAS Melanoma

France
Hellenic Cooperative Oncology Group

Completed

Corellation of Mutations, TILs and Age in Breast Cancer

Breast Cancer
British Thoracic Society

Completed

3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

Deep Vein Thrombosis | Pulmonary Embolism | Deep Vein Thrombosis With Pulmonary Embolism

United Kingdom
Fudan University

Recruiting

Clinical Phenotype and Omics Study of KCNQ2-related Epilepsy

KCNQ2-related Epilepsy

China
The Hong Kong Polytechnic University

Not yet recruiting

Rhythmic Auditory Stimulation on Upper-limb Movements in PD Patients

Parkinson Disease | Movement, Abnormal | Bradykinesia | Acoustic Stimulation | Arm
Assiut University

Unknown

Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic Syndrome

Nephrotic Syndrome Steroid-Resistant
Cephalon

Completed

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkin's Lymphoma (NHL)

United States, Belgium, Israel
University of Wisconsin, Madison
National Cancer Institute (NCI)

Enrolling by invitation

Cessation Screening Project

Nicotine Dependence

United States
Craig L Slingluff, Jr
National Cancer Institute (NCI)

Terminated

A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib (Mel61)

Melanoma

United States

Search clinical trials for: quantification of BRAF and NRAS mutation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations